| Dr Kristofer Hillegas, DO | |
|
1 Brace Rd Ste C1, Cherry Hill, NJ 08034-2600 | |
| (856) 428-4100 | |
| (856) 428-5748 |
| Full Name | Dr Kristofer Hillegas |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 1 Brace Rd Ste C1, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154594224 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Willingboro Hospital | Willingboro, NJ | Hospital |
| Virtua Our Lady Of Lourdes Hospital | Camden, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Despite the fact that bowel cancer is the third most common form of the disease in Britain and kills 16,000 people every year, the government watchdog on drugs the National Institute for Health and Clinical Excellence (NICE) has sparked a bitter controversy by refusing to provide two bowel cancer drugs on the National Health Service (NHS) to cancer patients.
In an opinion piece published Feb. 10 in the journal Science, a team of scholars led by a Johns Hopkins bioethicist urges the scientific community to act collectively to stem the negative effects of the patenting and privatizing of stem cell lines, data and pioneering technologies. This means grappling with the ambiguity of several fundamental distinctions typically made in ethics, law and common practice, the experts insist.
Researchers at Washington University School of Medicine in St. Louis have demonstrated a new approach to treating muscular dystrophy. Mice with a form of this muscle-weakening disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.
The New York Times: Veterans with post-traumatic stress disorder who are seeking disability benefits will get a break when new rules go into effect as early as next week.
› Verified 9 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Despite the fact that bowel cancer is the third most common form of the disease in Britain and kills 16,000 people every year, the government watchdog on drugs the National Institute for Health and Clinical Excellence (NICE) has sparked a bitter controversy by refusing to provide two bowel cancer drugs on the National Health Service (NHS) to cancer patients.
In an opinion piece published Feb. 10 in the journal Science, a team of scholars led by a Johns Hopkins bioethicist urges the scientific community to act collectively to stem the negative effects of the patenting and privatizing of stem cell lines, data and pioneering technologies. This means grappling with the ambiguity of several fundamental distinctions typically made in ethics, law and common practice, the experts insist.
Researchers at Washington University School of Medicine in St. Louis have demonstrated a new approach to treating muscular dystrophy. Mice with a form of this muscle-weakening disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.
The New York Times: Veterans with post-traumatic stress disorder who are seeking disability benefits will get a break when new rules go into effect as early as next week.
› Verified 9 days ago
| Entity Name | Lourdes Cardiology Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912202557 PECOS PAC ID: 5799961751 Enrollment ID: O20110510000163 |
News Archive
Despite the fact that bowel cancer is the third most common form of the disease in Britain and kills 16,000 people every year, the government watchdog on drugs the National Institute for Health and Clinical Excellence (NICE) has sparked a bitter controversy by refusing to provide two bowel cancer drugs on the National Health Service (NHS) to cancer patients.
In an opinion piece published Feb. 10 in the journal Science, a team of scholars led by a Johns Hopkins bioethicist urges the scientific community to act collectively to stem the negative effects of the patenting and privatizing of stem cell lines, data and pioneering technologies. This means grappling with the ambiguity of several fundamental distinctions typically made in ethics, law and common practice, the experts insist.
Researchers at Washington University School of Medicine in St. Louis have demonstrated a new approach to treating muscular dystrophy. Mice with a form of this muscle-weakening disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.
The New York Times: Veterans with post-traumatic stress disorder who are seeking disability benefits will get a break when new rules go into effect as early as next week.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristofer Hillegas, DO 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Dr Kristofer Hillegas, DO 1 Brace Rd Ste C1, Cherry Hill, NJ 08034-2600 Ph: (856) 428-4100 |
News Archive
Despite the fact that bowel cancer is the third most common form of the disease in Britain and kills 16,000 people every year, the government watchdog on drugs the National Institute for Health and Clinical Excellence (NICE) has sparked a bitter controversy by refusing to provide two bowel cancer drugs on the National Health Service (NHS) to cancer patients.
In an opinion piece published Feb. 10 in the journal Science, a team of scholars led by a Johns Hopkins bioethicist urges the scientific community to act collectively to stem the negative effects of the patenting and privatizing of stem cell lines, data and pioneering technologies. This means grappling with the ambiguity of several fundamental distinctions typically made in ethics, law and common practice, the experts insist.
Researchers at Washington University School of Medicine in St. Louis have demonstrated a new approach to treating muscular dystrophy. Mice with a form of this muscle-weakening disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.
The New York Times: Veterans with post-traumatic stress disorder who are seeking disability benefits will get a break when new rules go into effect as early as next week.
› Verified 9 days ago